Related Experiment Videos
CAFNet-DG: Task-Specific Modeling and Prevalence-Aware Evaluation for Adverse Drug Reaction Prioritization with
Wen Li1, Zhiyu Xu1, Xiangqiong Wu1
1College of Electronic Information, Hunan First Normal University, Changsha 410205, China.
Abstract:
Adverse drug reaction (ADR) prioritization and ordinal-frequency estimation are related but distinct prediction objectives, while aggregate ranking performance in sparse annotation matrices can be strongly influenced by frequently annotated side effects. Within CAFNet-DG, CAFNet-D uses task-specific association and ordinal-frequency functions built on shared molecular-relational representations, while annotation prevalence is evaluated explicitly within each training fold. On a SIDER-derived dataset comprising 750 drugs and 994 side effects, replacing a shared output with task-specific functions produced the largest joint change in staged drug-disjoint ablation, increasing mAP from 0.340 to 0.382 and reducing RMSE from 1.754 to 1.142. A prevalence-only ranking achieved an mAP of 0.410, close to the CAFNet-DG value of 0.413, indicating that aggregate ADR ranking is strongly associated with the benchmark annotation distribution. Prevalence-matched, prevalence-stratified, frequently annotated side-effect removal, and per-drug analyses were therefore used to distinguish drug-conditioned ranking variation from global annotation-prevalence effects. An equal-weight same-architecture ensemble control yielded no significant differences from CAFNet-DG across seven ranking metrics after Holm correction; generic variance reduction therefore could not be excluded as an explanation for the modest score-integration gain. Scaffold-disjoint and independent-data evaluations showed modest transfer, while ordinal-frequency agreement on CT-ADE remained limited. The results support the CAFNet-D task-specific formulation and prevalence-aware evaluation, while CAFNet-DG provides the score-integration setting examined under matched ensemble controls.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Dosage Regimens: Partial Pharmacokinetic Parameters
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Analysis of Population Pharmacokinetic Data